How to Get AndroGel in Maine: Prescriptions, Telehealth, Labs, and Pharmacies

Prescription access and medication affordability image for How to Get AndroGel in Maine: Prescriptions, Telehealth, Labs, and Pharmacies

At a glance

  • Drug name / AndroGel (testosterone gel 1% and 1.62%), AbbVie
  • DEA schedule / Schedule III controlled substance
  • Telehealth prescribing in Maine / Permitted for established patients after clinical evaluation
  • Compounding availability / Yes, via licensed 503A pharmacies shipping to Maine
  • MaineCare (Medicaid) coverage / Covered for male hypogonadism with prior authorization
  • Required baseline labs / Total testosterone (x2 morning draws), LH, FSH, CBC, PSA, metabolic panel
  • Diagnostic threshold / Two total testosterone readings below 300 ng/dL per Endocrine Society guidelines
  • Typical onset of symptom relief / 3 to 6 weeks for libido; 3 to 6 months for body composition
  • Transfer of out-of-state Rx / Permitted; Maine pharmacies must re-verify DEA compliance

What AndroGel Is and Why Maine Patients Seek It

AndroGel is the brand name for exogenous testosterone delivered in a hydroalcoholic gel applied once daily to the shoulders, upper arms, or abdomen. The 1% formulation delivers 25 mg or 50 mg testosterone per application; the 1.62% formulation delivers 20.25 mg or 40.5 mg per actuation. Both are FDA-approved by AbbVie for male hypogonadism, a condition defined by the Endocrine Society as "a clinical syndrome that results from failure of the testis to produce physiological levels of testosterone." [1]

Hypogonadism affects roughly 2.1% to 3.8% of men aged 40 to 79, with prevalence rising sharply after age 60. [2] Symptoms include reduced libido, fatigue, loss of lean mass, low mood, and impaired bone density. Maine has a comparatively older median population age (44.8 years, above the U.S. median of 38.9), meaning a meaningful share of the state's adult male population may meet clinical criteria.

The Testosterone Trials (T-Trials), a coordinated set of seven double-blind placebo-controlled studies (N=790 men aged 65 or older with total testosterone below 275 ng/dL), found that testosterone treatment for one year produced statistically significant improvements in sexual function, physical performance, and bone mineral density compared with placebo (P<0.001 for the sexual-function domain). [3] Those results underpin current prescribing norms and support the clinical rationale for evaluation.

Diagnostic Requirements Before Any Maine Prescriber Can Write the Prescription

Two confirmed morning testosterone readings below 300 ng/dL are required. No Maine prescriber, in-person or telehealth, can legally or ethically prescribe AndroGel without them.

The Endocrine Society's 2018 clinical practice guideline states: "We recommend against making a diagnosis of androgen deficiency in men with one low testosterone measurement because of the pulsatile secretion of testosterone and the diurnal variation in serum testosterone." [4] Samples must be drawn between 7 a.m. and 10 a.m. to capture peak endogenous production. A single low result is not sufficient.

The minimum pre-treatment lab panel recommended by the American Urological Association and the Endocrine Society includes: [4] [5]

  • Total serum testosterone (drawn on two separate mornings)
  • Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to distinguish primary from secondary hypogonadism
  • Complete blood count (CBC) to establish a baseline hematocrit before therapy
  • Prostate-specific antigen (PSA) in men aged 40 and older, or younger men at elevated prostate cancer risk
  • Basic metabolic panel
  • Sex hormone-binding globulin (SHBG) when total testosterone is borderline (300 to 400 ng/dL)

Quest Diagnostics and LabCorp both operate collection sites throughout Maine, including Bangor, Portland, Augusta, and Lewiston. Most telehealth TRT platforms operating in Maine provide a requisition form you take to your nearest draw site; results are typically returned within 24 to 72 hours. [6]

Which Clinicians in Maine Can Prescribe AndroGel

Physicians (MD, DO), nurse practitioners (NP), and physician assistants (PA) licensed in Maine can all prescribe Schedule III controlled substances, including testosterone gel, provided they hold an active DEA registration. Maine Title 32, Chapter 117 grants prescriptive authority for Schedule III medications to advanced practice registered nurses with a current controlled-substance license. [7]

Primary care physicians and urologists are the most common in-person prescribers. Endocrinologists manage complex cases, particularly secondary hypogonadism where a pituitary adenoma may be the underlying cause. NPs and PAs working in men's health or hormone clinics write a significant volume of TRT prescriptions statewide.

For telehealth, any provider must be licensed in Maine at the time of prescribing. Following the expiration of the federal COVID-19 public health emergency DEA flexibilities, controlled substances, including testosterone, generally require that a provider has conducted at least one in-person or synchronous audio-video evaluation before issuing a Schedule III prescription via telehealth. [8] Most Maine-compliant telehealth TRT platforms conduct a live video visit lasting 20 to 30 minutes before the first prescription is sent.

How to Get an AndroGel Prescription in Maine: Step-by-Step

Getting AndroGel in Maine follows a defined clinical sequence. Skipping any step delays the prescription.

Step 1. Choose an in-person or telehealth provider. Primary care offices in Maine typically schedule testosterone evaluations within two to four weeks. Telehealth platforms licensed in Maine can often schedule an initial video visit within 24 to 48 hours. Either path works.

Step 2. Order and complete baseline labs. Your provider sends a lab requisition. You complete the two morning testosterone draws on separate days (not the same day) along with the supporting panel described above. [4]

Step 3. Complete the clinical evaluation. A history and physical (or equivalent telehealth intake) reviews symptom burden using a validated tool such as the Aging Males' Symptoms (AMS) scale. The provider documents the indication, reviews contraindications (including polycythemia, untreated sleep apnea, active prostate cancer, and severe lower-urinary-tract symptoms), and confirms the lab findings. [4]

Step 4. Receive the prescription. Maine pharmacies accept both paper and electronic prescriptions for Schedule III substances. E-prescribing for controlled substances (EPCS) is legally permitted in Maine under the Maine Revised Statutes Title 22, Section 2392. [9]

Step 5. Submit prior authorization if required. Most commercial plans and MaineCare require PA before dispensing brand AndroGel. The PA process is outlined in detail in the section below.

Step 6. Fill at a retail or mail-order pharmacy. AndroGel is available at national chain pharmacies in Maine (CVS, Walgreens, Rite Aid, Hannaford Pharmacy). GoodRx pricing for AndroGel 1.62% 75 g puts the cash price in Maine at approximately $280 to $350 per month; generic testosterone gel 1% is significantly less at roughly $60 to $90.

Telehealth Prescribing of AndroGel in Maine

Maine permits telehealth prescribing of controlled substances for established patients following a qualifying clinical evaluation. Several national men's health telehealth platforms are licensed in Maine and actively prescribe testosterone therapy.

The key regulatory boundary: the DEA's 2023 Special Registration telemedicine rule proposal, still pending finalization as of mid-2025, requires an audio-video evaluation before the first Schedule III prescription in most circumstances. [8] Providers operating only via asynchronous questionnaire cannot legally issue the first AndroGel prescription in Maine.

After the initial video visit and lab review, refill prescriptions can be managed via asynchronous follow-up messages on most platforms. Monitoring labs (hematocrit, testosterone trough, PSA) are typically required every three to six months in the first year. [4] [10]

Telehealth has measurably improved access in rural Maine counties. Providers in Aroostook, Washington, and Piscataquis counties, where endocrinologists and urologists are sparse, report that telehealth accounts for the majority of new TRT evaluations in those areas.

The HealthRX Maine TRT Pathway summarizes prescriber type, minimum visit requirements, schedule III DEA compliance, and monitoring cadence in a single decision tree that the medical team uses during patient intake triage.

Prior Authorization for AndroGel in Maine: What to Expect

Prior authorization (PA) is required by most Maine commercial insurers and by MaineCare for brand AndroGel. PA approval rates are high when the clinical file is complete.

MaineCare (Maine's Medicaid program) covers AndroGel for male hypogonadism under the preferred drug list when the following are documented: [11]

  • Two total testosterone values below 300 ng/dL drawn on separate mornings
  • Clinical symptoms consistent with hypogonadism
  • Documentation that the diagnosis is not attributable to a reversible cause (opioid-induced hypogonadism, obesity-related hypogonadotropism, or medication effect) without first addressing that cause
  • PSA below 4 ng/mL (or lower thresholds per individual plan policy) with no active prostate cancer

The PA form is submitted by the prescribing provider, not the patient. Most MaineCare PA decisions for AndroGel are returned within 72 hours. Commercial plan timelines vary from 24 hours to 14 days depending on the insurer. [12]

If PA is denied, the most common grounds are: testosterone values drawn outside the morning window, only one (not two) low testosterone results in the file, or documentation of a reversible cause not yet addressed. Each of those is correctable on appeal.

Generic testosterone gel and compounded gel typically do not require PA because their lower cost falls below most plan thresholds for utilization management review. Switching from brand to generic or compounded can eliminate the PA requirement entirely while delivering the same active molecule.

503A Compounding Pharmacies and Testosterone Gel in Maine

Maine residents have access to testosterone gel compounded by 503A pharmacies, state-licensed retail compounding pharmacies that may ship to Maine patients when a valid prescription exists.

503A pharmacies compound testosterone gel in concentrations not commercially available (such as 2%, 5%, or 10%) and in vehicles suited to patient preference. Compounded testosterone is not FDA-approved as a finished drug product, but the active pharmaceutical ingredient (testosterone USP) must meet USP <795> and <797> quality standards. [13] The FDA's guidance on pharmacy compounding specifies that 503A pharmacies must be licensed in the state where they operate and must compound on a patient-specific prescription basis. [14]

The Maine Board of Pharmacy requires that any out-of-state 503A pharmacy shipping into Maine hold a non-resident pharmacy permit. Patients should verify this permit before accepting a compounded testosterone product. A list of licensed non-resident pharmacies is maintained by the Maine Board of Pharmacy. [15]

Compounded testosterone gel is not interchangeable with brand AndroGel for insurance reimbursement purposes; it is almost always a cash-pay product. Monthly costs for compounded testosterone gel from reputable 503A pharmacies typically range from $40 to $120, depending on concentration and quantity.

Monitoring Requirements After Starting AndroGel in Maine

Starting AndroGel is the beginning of a managed clinical process. Monitoring is not optional.

The Endocrine Society recommends checking serum testosterone (trough or mid-interval) at three to six months after initiation to confirm the patient is within the target therapeutic range of 400 to 700 ng/dL, followed by annual monitoring once stable. [4] Hematocrit must be checked at three months, six months, and annually; if hematocrit exceeds 54%, therapy should be held and the dose reduced or the formulation changed. [4] [10]

PSA monitoring follows the same cadence as age-appropriate prostate cancer screening. The Endocrine Society guideline states: "We suggest monitoring PSA levels and performing a digital rectal examination at 3 to 6 months after initiating testosterone therapy and then according to guidelines for prostate cancer screening." [4]

Bone mineral density by DEXA scan is recommended at 1 to 2 years in men who had osteoporosis or low bone density at baseline. [4]

The T-Trials bone-density sub-study (N=211) found that men receiving testosterone therapy for 12 months showed a 7.5% increase in volumetric bone mineral density at the trabecular spine compared with a 0.8% increase in the placebo group (P<0.001). [3] That magnitude of change is clinically meaningful for fracture-risk reduction.

Transferring an Out-of-State AndroGel Prescription to Maine

Maine accepts transferred Schedule III prescriptions from out-of-state pharmacies under federal DEA regulations, but specific requirements apply.

Federal law (21 CFR Part 1306) permits the transfer of a Schedule III prescription between pharmacies once only. The receiving Maine pharmacy must confirm the transferring pharmacy's DEA registration, obtain the original prescription information, and record the transfer. [16] The prescribing provider does not need to rewrite the prescription unless the transfer has already been used.

If you are relocating to Maine and your current AndroGel prescription has remaining refills, call the receiving Maine pharmacy with the details of your current prescription before you move. One clean phone-to-phone transfer between pharmacists exhausts the transfer allowance. After that, a new prescription from a Maine-licensed (or telehealth-licensed-in-Maine) provider is required.

Mail-order pharmacies operating nationwide and holding Maine non-resident pharmacy permits can continue filling an existing prescription for Maine patients without requiring a new prescription, as long as the prescribing provider remains licensed (or is telehealth-licensed in Maine).

Cost Reduction Strategies for AndroGel in Maine

Brand AndroGel carries a high list price. Several strategies lower out-of-pocket cost.

AbbVie's AndroGel savings card reduces cost-sharing for commercially insured patients to as low as $0 per month (subject to plan type and income eligibility). The card is not valid for government-insured patients, including MaineCare or Medicare. [17]

Generic testosterone gel 1% (available from multiple manufacturers including Perrigo and Lannett) costs substantially less than brand and delivers the same labeled dose. The FDA's AB-rated generic is therapeutically equivalent to AndroGel 1%. [18]

Compounded testosterone gel from a licensed 503A pharmacy, as described above, is the lowest-cost option for cash-pay patients, typically $40 to $120 per month.

GoodRx, RxSaver, and similar discount programs provide manufacturer-independent savings at Maine retail pharmacies for the generic product. These programs are accepted at most Maine chain pharmacies and do not require insurance enrollment.

Safety Considerations Specific to Maine Patients

Application-site transfer is a safety concern for all AndroGel patients but warrants specific attention in households with children or female partners. The FDA issued a black-box warning in 2009 requiring AndroGel labeling to prominently describe the risk of secondary exposure in women and children who contact the application site. [19] Gel should be allowed to dry fully (three to five minutes) and the site covered with clothing before skin-to-skin contact occurs. Washing the site with soap and water before contact further reduces transfer risk.

Maine's cold climate may also affect application. Applying testosterone gel to cold, vasoconstricted skin may reduce absorption temporarily; patients should apply gel to clean, dry skin that has been warmed to room temperature, not applied immediately after coming in from subzero conditions.

AndroGel is contraindicated in women who are or may become pregnant, nursing mothers, and men with breast or prostate cancer. [19] These contraindications are absolute regardless of state of residence.

The FDA MedWatch program accepts adverse-event reports for AndroGel at fda.gov/safety/medwatch, and providers in Maine are expected to report serious adverse events through that system. [20]

Frequently asked questions

How do I get an AndroGel prescription in Maine?
You need two morning total testosterone blood draws below 300 ng/dL, a clinical evaluation documenting hypogonadism symptoms, and a prescription from a Maine-licensed prescriber (MD, DO, NP, or PA with DEA registration). The evaluation can be done in person or via a synchronous telehealth video visit with a provider licensed in Maine.
What labs are needed before AndroGel in Maine?
The Endocrine Society recommends two morning total testosterone measurements drawn on separate days, plus LH, FSH, CBC, PSA (age 40 and older), SHBG (if testosterone is borderline), and a basic metabolic panel. Both draws must be collected between 7 a.m. and 10 a.m.
Are there telehealth providers in Maine prescribing AndroGel?
Yes. Several national men's health telehealth platforms hold Maine medical licenses and can evaluate and prescribe AndroGel after a synchronous audio-video visit and confirmed lab results. Asynchronous-only (questionnaire-only) platforms cannot legally issue the first Schedule III prescription in Maine under current DEA rules.
How long until I receive AndroGel in Maine?
From first contact to first dose, the typical timeline is 7 to 21 days: 1 to 3 days to schedule, 2 to 5 days for labs, 1 to 3 days for the clinical visit and prescription, and 1 to 7 days for pharmacy dispensing or mail delivery. Prior authorization adds 1 to 14 days if required by your insurer.
Can I transfer an AndroGel prescription to Maine?
Yes. Federal DEA regulations permit one transfer of a Schedule III prescription between pharmacies. The receiving Maine pharmacy contacts your current pharmacy, records the original prescription data, and can dispense remaining refills. After that single transfer, a new prescription from a Maine-licensed provider is required.
Are 503A pharmacies in Maine licensed to ship testosterone gel?
Yes, provided the pharmacy holds a valid Maine non-resident pharmacy permit (for out-of-state compounders) or is a licensed Maine 503A pharmacy. The compounded testosterone gel requires a patient-specific prescription and must comply with USP standards. Compounded products are not FDA-approved finished drugs and are typically cash-pay.
Who can prescribe AndroGel in Maine: MD vs NP vs PA?
All three can prescribe AndroGel in Maine. MDs and DOs prescribe under their full medical license. NPs with a controlled-substance license under Maine Title 32, Chapter 117 can prescribe Schedule III medications independently. PAs can also prescribe Schedule III substances with an active DEA registration in Maine.
What documentation does prior authorization require in Maine?
For MaineCare and most commercial plans, PA requires: two total testosterone values below 300 ng/dL with morning draw documentation, a signed clinical note confirming hypogonadism symptoms, confirmation that reversible causes have been evaluated, and a PSA below 4 ng/mL with no active prostate cancer. The prescribing provider submits the PA; most MaineCare decisions return within 72 hours.

References

  1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  2. Araujo AB, O'Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004;89(12):5920-5926. https://pubmed.ncbi.nlm.nih.gov/15579737/
  3. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
  4. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  5. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/
  6. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005;26(6):833-876. https://pubmed.ncbi.nlm.nih.gov/16179424/
  7. Maine Legislature. Title 32, Chapter 117: Nurse Practitioners. https://legislature.maine.gov/statutes/32/title32ch117.pdf
  8. Drug Enforcement Administration. Telemedicine Prescribing of Controlled Substances: Proposed Rule. Federal Register 2023. https://www.fda.gov/
  9. Maine Revised Statutes Title 22, Section 2392: Electronic Prescribing. https://legislature.maine.gov/statutes/22/title22sec2392.html
  10. Snyder PJ, Ellenberg SS, Cunningham GR, et al. The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials. 2014;11(3):362-375. https://pubmed.ncbi.nlm.nih.gov/24713312/
  11. MaineCare Benefits Manual. Preferred Drug List and Prior Authorization Criteria. Maine Department of Health and Human Services. https://www.maine.gov/dhhs/oms/rules/index.shtml
  12. Centers for Medicare and Medicaid Services. Prior Authorization and Step Therapy. https://www.cms.gov/
  13. U.S. Pharmacopeia. <795> Pharmaceutical Compounding: Nonsterile Preparations. https://www.usp.org/
  14. U.S. Food and Drug Administration. Pharmacy Compounding Overview. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-overview
  15. Maine Board of Pharmacy. Non-Resident Pharmacy Permits. https://www.maine.gov/pfr/professionallicensing/professions/pharmacy/
  16. Drug Enforcement Administration. 21 CFR Part 1306: Prescriptions. https://www.ecfr.gov/current/title-21/chapter-II/part-1306
  17. AbbVie. AndroGel Patient Savings Program. Accessed 2025. https://www.androgel.com/
  18. U.S. Food and Drug Administration. Orange Book: Approved Drug Products With Therapeutic Equivalence Evaluations. Testosterone gel entries. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
  19. U.S. Food and Drug Administration. AndroGel Prescribing Information (Full Label). AbbVie Inc. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020888s038lbl.pdf
  20. U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. https://www.fda.gov/safety/medwatch